CoreAge Rx review

The current public offer is $79 or $129, flat across doses

CoreAge Rx is a featured partner on this site and is assessed under our published Metabolic-Fit weighting. That assessment is editorial judgment, not a clinical recommendation or proof that it is the best provider for every mother. The official public offer reached from its product route now lists compounded semaglutide at $79 per month and tirzepatide at $129, at the same price across doses. It describes a fixed refill price, no membership or hidden fees, and free overnight cold shipping. These are current advertised standing service prices, rather than a completed personal checkout quote. The older $99 and $149 signup observations remain historical.

A prescriber who reads your history — not an intake quiz

CoreAge's earlier intake observation included questions about pregnancy, breastfeeding and plans to conceive, followed by clinician review. That is relevant background for someone whose treatment timing depends on a nursing window or another pregnancy. It does not establish a dedicated obstetric service or guarantee a particular conversation in every case. Ask who will review your history, how you reach that clinician and whether a live visit is needed for your state. A medical questionnaire is part of the process, rather than evidence that an application will be approved.

To be clear about what that does and doesn't mean: no GLP-1 — compounded or brand — is established as safe during pregnancy. For breastfeeding, the injectable labels ask you and your clinician to weigh the benefits of breastfeeding against your need for the medicine, and compounded versions carry no label of their own. CoreAge doesn't change that, and a responsible provider shouldn't pretend to. What it offers is a clinician who will help you plan the timing around those windows with your own OB in the loop, which is a very different thing from a checkout flow that never asks.

Both molecules on one account — which matters more for mothers than it sounds

CoreAge offers compounded semaglutide and tirzepatide. Its earlier account observation supported switching without starting a separate enrollment, but any change in medicine still needs the clinician's assessment and a current financial quote. PCOS, insulin resistance or a history of gestational diabetes alone does not establish which medicine is appropriate. Ask how a switch changes the preparation, supply, payment and follow-up rather than assuming that a shared account makes the products interchangeable. Our semaglutide and tirzepatide comparison discusses the evidence separately from a seller's account features.

One-time purchases and fixed refill prices are separate promises

The public offer describes a one-time purchase without a required subscription. Its fixed-refill-price statement explains the advertised price if treatment continues; it should not be read as proof that another payment is automatically authorized. Confirm how to request the next purchase, the prescription quantity and shipping schedule, and what happens if the clinician changes the medicine. No health answers were supplied during this public-price recheck, so it does not establish anyone's eligibility or final order. State access still varies by therapy according to the FAQ. Check the actual prescription and address rather than assuming uninterrupted access in all fifty states.

Where CoreAge Rx isn't the answer

CoreAge offers compounded medication rather than an established FDA-approved brand lane in the program reviewed here. Someone specifically seeking a Wegovy or Zepbound brand product should identify an appropriate service and prescription route. It is also a general metabolic program, not a dedicated obstetric or hormone practice. The advertised $79 and $129 amounts help compare published cash offers, but the actual preparation, quantity, clinician access and monitoring still need to fit the patient. Compare those features alongside the payment terms, and see the wider field in our best GLP-1 for women ranking.

The financial boundary before a refill

The terms permit cancellation before clinical review is completed and before the prescription is sent to a pharmacy. After review or transmission, an order is generally nonrefundable under the stated policy. Orders held for an incomplete intake can also be treated as completed services after thirty days. Those rules apply to the current purchase even when a subscription is not required. Deciding against another order is different from recovering a payment for work or fulfillment already underway. Ask how to cancel the present order and how a later repurchase is authorized, with the actual prescription, state eligibility and pharmacy identified before paying.